|
Feb 25
|
ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs
|
|
Feb 20
|
ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables
|
|
Feb 18
|
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports
|
|
May 10
|
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2024 Earnings Call Transcript
|
|
May 9
|
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated
|
|
May 9
|
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
|
|
May 2
|
ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
May 2
|
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
|
|
Apr 29
|
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
|
|
Apr 25
|
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
|
|
Apr 16
|
ProPhase Labs Unveils Project ZenQ-AI
|
|
Apr 15
|
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
|
|
Apr 10
|
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024
|
|
Apr 2
|
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
|
Mar 18
|
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript
|
|
Mar 18
|
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
|
|
Mar 15
|
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives
|
|
Mar 8
|
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
|
|
Jan 4
|
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
|
|
Nov 2
|
ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time
|